Robert Salomon

Personal Home Page

http://www.case.edu/artsci/chem/faculty/salomon/salomon.html

Articles in Scholarly Journals [Incomplete List]

  1. Conformation of an Endogenous Ligand in a Membrane Bilayer for the Macrophage Scavenger Receptor CD36
    Biochemistry, vol. 46, no. 17, pp. 5009–5017, 2007
  2. Fe2+ Catalyzes Vitamin E-Induced Fragmentation of Hydroperoxy and Hydroxy Endoperoxides That Generates ?-Hydroxy Alkenals
    Journal of the American Chemical Society, vol. 129, no. 19, pp. 6088–6089, 2007
  3. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
    Nature Medicine, vol. 13, no. 9, Article ID nm1626, 9 pages, 2007
  4. Serum Vitamin E and Oxidative Protein Modification in Hemodialysis: A Randomized Clinical Trial
    American Journal of Kidney Diseases, vol. 50, no. 2, pp. 305–313, 2007
  5. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration
    Proceedings of the National Academy of Sciences, vol. 103, no. 36, pp. 13480–13484, 2006
  6. Light-induced Oxidation of Photoreceptor Outer Segment Phospholipids Generates Ligands for CD36-mediated Phagocytosis by Retinal Pigment Epithelium: A POTENTIAL MECHANISM FOR MODULATING OUTER SEGMENT PHAGOCYTOSIS UNDER OXIDANT STRESS CONDITIONS
    Journal of Biological Chemistry, vol. 281, no. 7, pp. 4222–4230, 2006
  7. Phospholipid Hydroxyalkenals, a Subset of Recently Discovered Endogenous CD36 Ligands, Spontaneously Generate Novel Furan-containing Phospholipids Lacking CD36 Binding Activity in Vivo
    Journal of Biological Chemistry, vol. 281, no. 42, pp. 31298–31308, 2006
  8. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products
    The Journal of Lipid Research, vol. 47, no. 9, pp. 1967–1974, 2006
  9. The Journal of Organic Chemistry, vol. 71, no. 15, pp. 5607–5615, 2006
  10. Chemical Research in Toxicology, vol. 19, no. 2, pp. 262–271, 2006
  11. Isolevuglandins, Oxidatively Truncated Phospholipids, and Atherosclerosis
    Annals of the New York Academy of Sciences, vol. 1043, no. 1, pp. 327–342, 2005
  12. Levuglandins and Isolevuglandins: Stealthy Toxins of Oxidative Injury
    Antioxidants Redox Signaling, vol. 7, no. 1-2, pp. 185–201, 2005
  13. An Efficient Synthesis of 4-Oxoalkenoic Acids from 2-Alkylfurans
    Synlett, no. 9, pp. 1468–1470, 2005
  14. Oxidized phospholipids, isolevuglandins, and atherosclerosis
    Molecular Nutrition & Food Research, vol. 49, no. 11, pp. 1050–1062, 2005
  15. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways
    Chemistry and Physics of Lipids, vol. 134, no. 1, pp. 1–20, 2005
  16. Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse
    Experimental Eye Research, vol. 80, no. 5, pp. 741–744, 2005
  17. Journal of the American Chemical Society, vol. 126, no. 18, pp. 5699–5708, 2004
  18. Journal of the American Chemical Society, vol. 126, no. 37, pp. 11522–11528, 2004
  19. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo
    The FASEB Journal, vol. 17, no. 15, pp. 2209–2220, 2003
  20. Phospholipid Hydroxyalkenals: Biological and Chemical Properties of Specific Oxidized Lipids Present in Atherosclerotic Lesions
    Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 275–282, 2003
  21. Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration
    Journal of Biological Chemistry, vol. 278, no. 43, pp. 42027–42035, 2003
  22. The Journal of Organic Chemistry, vol. 68, no. 10, pp. 3749–3761, 2003
  23. Organic Letters, vol. 5, no. 16, pp. 2797–2799, 2003
  24. The Journal of Organic Chemistry, vol. 67, no. 11, pp. 3575–3584, 2002
  25. Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36
    Journal of Biological Chemistry, vol. 277, no. 41, pp. 38503–38516, 2002
  26. A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions
    Journal of Biological Chemistry, vol. 277, no. 41, pp. 38517–38523, 2002
  27. From the Cover: Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
    Proceedings of the National Academy of Sciences, vol. 99, no. 23, pp. 14682–14687, 2002
  28. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells
    Vascular Pharmacology, vol. 38, no. 4, pp. 201–209, 2002
  29. Isolevuglandin-protein Adducts in Oxidized Low Density Lipoprotein and Human Plasma A Strong Connection with Cardiovascular Disease
    Trends in Cardiovascular Medicine, vol. 10, no. 2, pp. 53–59, 2000
  30. Isolevuglandin–protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1485, no. 2-3, pp. 225–235, 2000
  31. Journal of Organic Chemistry, vol. 65, no. 17, pp. 5315–5326, 2000
  32. Journal of Organic Chemistry, vol. 65, no. 20, pp. 6660–6665, 2000
  33. Chemical Research in Toxicology, vol. 13, no. 7, pp. 557–564, 2000
  34. Journal of Organic Chemistry, vol. 64, no. 4, pp. 1218–1224, 1999
  35. Identification of Extremely Reactive gamma -Ketoaldehydes (Isolevuglandins) as Products of the Isoprostane Pathway and Characterization of Their Lysyl Protein Adducts
    Journal of Biological Chemistry, vol. 274, no. 19, pp. 13139–13146, 1999
  36. Protein Adducts of Iso[4]levuglandin E2, a Product of the Isoprostane Pathway, in Oxidized Low Density Lipoprotein
    Journal of Biological Chemistry, vol. 274, no. 29, pp. 20271–20280, 1999
  37. Biochemistry, vol. 38, no. 51, pp. 16904–16915, 1999
  38. Advanced lipid peroxidation end-products in Alexander's disease
    Brain Research, vol. 787, no. 1, pp. 15–18, 1998
  39. Journal of Organic Chemistry, vol. 63, no. 10, pp. 3504–3507, 1998
  40. Journal of Organic Chemistry, vol. 62, no. 22, pp. 7658–7666, 1997
  41. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo
    Journal of Biological Chemistry, vol. 272, no. 21, pp. 13597–13607, 1997
  42. Chemical Research in Toxicology, vol. 10, no. 5, pp. 536–545, 1997
  43. Chemical Research in Toxicology, vol. 10, no. 7, pp. 750–759, 1997
  44. (Carboxyalkyl)pyrroles in Human Plasma and Oxidized Low-Density Lipoproteins
    Chemical Research in Toxicology, vol. 10, no. 12, pp. 1387–1396, 1997
  45. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid
    Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol. 1344, no. 1, pp. 1–5, 1997
  46. Chemical Research in Toxicology, vol. 9, no. 7, pp. 1194–1201, 1996
  47. Formation and Stability of Pyrrole Adducts in the Reaction of Levuglandin E2 with Proteins
    Chemical Research in Toxicology, vol. 8, no. 1, pp. 61–67, 1995
  48. A short synthesis of the antimitotic allylic diepoxide functional array of spatol
    Tetrahedron Letters, vol. 35, no. 41, pp. 517–520, 1994
  49. Journal of Organic Chemistry, vol. 59, no. 20, pp. 6038–6043, 1994
  50. Journal of Organic Chemistry, vol. 59, no. 20, pp. 6044–6050, 1994
  51. Total synthesis of halichondrin b from common sugars: An F-ring intermediate from D-glucose and efficient construction of the C1 to C21 segment
    Tetrahedron Letters, vol. 34, no. 51, pp. 8193–8196, 1993
  52. Total synthesis of halichondrins: Enantioselective construction of a homochiral tetracyclic KLMN-ring intermediate from D-mannitol
    Tetrahedron Letters, vol. 34, no. 20, pp. 3247–3250, 1993
  53. Chemical Research in Toxicology, vol. 6, no. 1, pp. 19–22, 1993
  54. Physiological evidence for the possible existence of anhydrolevuglandin E2-like activity in extracts and media from uteri of rats
    Prostaglandins, vol. 43, no. 6, pp. 573–582, 1992
  55. Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 47, no. 2, pp. 105–110, 1992
  56. Journal of the American Chemical Society, vol. 113, no. 8, pp. 3085–3095, 1991
  57. Journal of the American Chemical Society, vol. 113, no. 8, pp. 3096–3106, 1991
  58. Total synthesis of halichondrins: Enantioselective construction of a homochiral pentacyclic C1-C15 intermediate from ?-ribose
    Tetrahedron Letters, vol. 31, no. 27, pp. 3813–3816, 1990
  59. Levuglandin E2 inhibits mitosis and microtubule assembly
    Prostaglandins, vol. 39, no. 6, pp. 611–622, 1990
  60. Electrophilic levuglandin E2-protein adducts bind glycine: A model for protein crosslinking
    Prostaglandins, vol. 40, no. 2, pp. 187–203, 1990
  61. Journal of Organic Chemistry, vol. 55, no. 10, pp. 3164–3175, 1990
  62. Journal of Organic Chemistry, vol. 55, no. 10, pp. 3175–3180, 1990
  63. Journal of Organic Chemistry, vol. 54, no. 7, pp. 1562–1570, 1989
  64. Journal of Organic Chemistry, vol. 54, no. 11, pp. 2628–2632, 1989
  65. Levuglandin E2 crosslinks proteins
    Prostaglandins, vol. 37, no. 4, pp. 471–480, 1989
  66. Total synthesis of (+)-spatol. A stereospecific construction of vicinal diepoxides from 2,3-epoxy-1,4-diols
    Tetrahedron Letters, vol. 30, no. 35, pp. 4621–4624, 1989
  67. Total synthesis of halichondrins: Highly stereoselective construction of a homochiral pentasubstituted H-ring pyran intermediate from a-d-glucose
    Tetrahedron Letters, vol. 30, no. 46, pp. 6279–6282, 1989
  68. Anhydrolevuglandin D2 inhibits the uterotonic acivity of prostaglandins F2a and D2
    Prostaglandins, vol. 35, no. 1, pp. 115–122, 1988
  69. Journal of the American Chemical Society, vol. 110, no. 15, pp. 5213–5214, 1988
  70. Journal of Organic Chemistry, vol. 53, no. 16, pp. 3673–3680, 1988
  71. Journal of Organic Chemistry, vol. 53, no. 16, pp. 3681–3688, 1988
  72. Journal of Organic Chemistry, vol. 53, no. 16, pp. 3688–3695, 1988
  73. Purification of a Water-Sensitive Natural Product with an Aprotic CPC Solvent System
    Journal of Liquid Chromatography & Related Technologies, vol. 11, no. 12, pp. 2507–2515, 1988
  74. Journal of Organic Chemistry, vol. 52, no. 1, pp. 83–90, 1987
  75. Journal of Organic Chemistry, vol. 52, no. 6, pp. 1072–1078, 1987
  76. Effects of E2 levuglandins on the contractile activity of the rat uterus
    Prostaglandins, vol. 34, no. 1, pp. 91–98, 1987
  77. Prostaglandin endoperoxidase 21. Covalent binding of levuglandin E2 with proteins
    Prostaglandins, vol. 34, no. 5, pp. 643–656, 1987
  78. Journal of the American Chemical Society, vol. 108, no. 6, pp. 1311–1312, 1986
  79. Journal of Organic Chemistry, vol. 51, no. 9, pp. 1393–1401, 1986
  80. Journal of Organic Chemistry, vol. 51, no. 13, pp. 2556–2562, 1986
  81. Journal of Organic Chemistry, vol. 50, no. 23, pp. 4484–4490, 1985
  82. Accounts of Chemical Research, vol. 18, no. 10, pp. 294–301, 1985
  83. Total synthesis of anhydro levuglandin D2
    Tetrahedron Letters, vol. 25, no. 41, pp. 4633–4636, 1984
  84. Journal of the American Chemical Society, vol. 106, no. 6, pp. 1750–1759, 1984
  85. Journal of the American Chemical Society, vol. 106, no. 7, pp. 2211–2213, 1984
  86. Journal of the American Chemical Society, vol. 106, no. 13, pp. 3797–3802, 1984
  87. Journal of the American Chemical Society, vol. 106, no. 20, pp. 6049–6060, 1984
  88. Journal of the American Chemical Society, vol. 106, no. 26, pp. 8296–8298, 1984
  89. Journal of Organic Chemistry, vol. 49, no. 13, pp. 2446–2454, 1984
  90. Journal of Organic Chemistry, vol. 49, no. 19, pp. 3659–3660, 1984
  91. Journal of Organic Chemistry, vol. 49, no. 22, pp. 4322–4324, 1984
  92. Journal of Organic Chemistry, vol. 48, no. 19, pp. 3182–3189, 1983
  93. Journal of Organic Chemistry, vol. 47, no. 24, pp. 4692–4702, 1982
  94. Journal of the American Chemical Society, vol. 104, no. 4, pp. 998–1007, 1982
  95. Journal of the American Chemical Society, vol. 104, no. 4, pp. 1008–1013, 1982
  96. Journal of the American Chemical Society, vol. 104, no. 12, pp. 3498–3503, 1982
  97. Journal of the American Chemical Society, vol. 104, no. 24, pp. 6841–6842, 1982
  98. Journal of Organic Chemistry, vol. 47, no. 5, pp. 829–836, 1982
  99. Journal of Organic Chemistry, vol. 46, no. 12, pp. 2598–2599, 1981
  100. Journal of the American Chemical Society, vol. 102, no. 7, pp. 2473–2475, 1980
  101. Journal of the American Chemical Society, vol. 102, no. 7, pp. 2501–2503, 1980
  102. Journal of the American Chemical Society, vol. 101, no. 6, pp. 1533–1539, 1979
  103. Journal of the American Chemical Society, vol. 101, no. 10, pp. 2761–2763, 1979
  104. Journal of the American Chemical Society, vol. 101, no. 14, pp. 3961–3963, 1979
  105. Journal of the American Chemical Society, vol. 101, no. 15, pp. 4290–4299, 1979
  106. Journal of Organic Chemistry, vol. 44, no. 22, pp. 3784–3790, 1979
  107. Journal of Organic Chemistry, vol. 43, no. 12, pp. 2438–2442, 1978
  108. Journal of Organic Chemistry, vol. 43, no. 21, pp. 4247–4248, 1978
  109. Journal of the American Chemical Society, vol. 100, no. 2, pp. 520–526, 1978
  110. Journal of the American Chemical Society, vol. 100, no. 2, pp. 660–662, 1978
  111. Crystal and molecular structure of 1,4-diphenyl-2,3-dioxabicyclo[2,2,1] heptane, C17H16O2
    Journal of Crystal and Molecular Structure, vol. 8, no. 5, pp. 239–246, 1978
  112. Journal of the American Chemical Society, vol. 99, no. 2, pp. 655–657, 1977
  113. Journal of the American Chemical Society, vol. 99, no. 4, pp. 1043–1054, 1977
  114. Journal of the American Chemical Society, vol. 99, no. 10, pp. 3500–3501, 1977
  115. Journal of the American Chemical Society, vol. 99, no. 10, pp. 3501–3503, 1977
  116. Journal of the American Chemical Society, vol. 99, no. 13, pp. 4372–4379, 1977
  117. Journal of Organic Chemistry, vol. 42, no. 21, pp. 3360–3364, 1977
  118. Journal of Organic Chemistry, vol. 41, no. 9, pp. 1529–1534, 1976
  119. Journal of Organic Chemistry, vol. 41, no. 17, pp. 2918–2920, 1976
  120. Journal of Organic Chemistry, vol. 41, no. 25, pp. 3983–3987, 1976
  121. Journal of the American Chemical Society, vol. 98, no. 23, pp. 7454–7456, 1976
  122. Journal of the American Chemical Society, vol. 97, no. 4, pp. 857–865, 1975
  123. Journal of the American Chemical Society, vol. 97, no. 21, pp. 6214–6221, 1975
  124. Journal of Organic Chemistry, vol. 40, no. 6, pp. 756–760, 1975
  125. Journal of Organic Chemistry, vol. 40, no. 10, pp. 1488–1492, 1975
  126. Journal of Organic Chemistry, vol. 39, no. 24, pp. 3602–3602, 1974
  127. Journal of the American Chemical Society, vol. 95, no. 6, pp. 1889–1897, 1973
  128. Journal of the American Chemical Society, vol. 95, no. 10, pp. 3300–3310, 1973
  129. Acetone-sensitized photoepimerization about unactivated tertiary carbon atoms
    Tetrahedron Letters, vol. 14, no. 44, pp. 4387–4390, 1973
  130. Journal of the American Chemical Society, vol. 94, no. 10, pp. 3643–3644, 1972
  131. Cationic benzene and olefin complexes of copper(I) trifluoromethanesulphonate
    Journal of the Chemical Society, Chemical Communications, no. 9, p. 559, 1972
  132. Journal of the American Chemical Society, vol. 93, no. 18, pp. 4620–4621, 1971